Cigna Health Services Business announces a significant new way we’re advancing healthcare. We are proud to introduce Embarc Benefit ProtectionSM, the industry’s first solution to begin to address the high cost of certain potentially curative gene therapy medicines.
Embarc Benefit Protection fills a critical, unmet need that offers a pathway for payers to provide coverage for some of these potentially life-altering cures under their plans. They will now be within reach for individuals covered by a plan with an Embarc solution. Focused on making these breakthrough drugs more affordable for payers and ensuring access to coverage for customers, this solution draws upon the collective capabilities of eviCore, Accredo, Express Scripts and Cigna, demonstrating the power of our combined organization. We anticipate Embarc Benefit Protection will be available in 2020.
Learn more here.